US Department of Health and Human Services, National Institutes of Health, Office of Dietary Supplements
Research goals: Metabolic & Weight Description AOD-9604 (CAS 221231-10-3) is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment of human growth hormone (hGH 177191) with an additional N-terminal tyrosine added to enhance stability
Note, however, that Medicare doesnt cover B12 injections to strengthen the foot tendons or ligaments
In this article, well explore what users are saying about AOD 9604, the potential benefits, and its drawbacks
Unlike full-length growth hormone, which can cause edema (fluid retention), joint pain, carpal tunnel syndrome, glucose elevation, and increased IGF-1, AOD-9604 demonstrates none of these effects in clinical trials
Benefits Beyond the Scale: Why This Combo Changes Everything When tirzepatide and Vitamin B12 injections are thoughtfully combined under medical supervision, the result is more than just numbers shifting on the scale